Therapeutic trials actively recruiting
Pancreatic ductal adenocarcinoma
|
Study Title |
National Clinical Trial number |
Phase |
Contact |
|
Phase II Trial of AZD6738 Alone and in Combination With Olaparib |
II |
Erika Zigman (415) 353-7381 |
|
|
A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab |
I |
Lily Stander (415) 353-4084 |
|
|
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers |
I |
Paige Black (415) 476-5947 |
|
|
A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants with Metastatic Pancreatic Ductal Adenocarcinoma |
I/II |
Nancy Kaushal (415) 514-7633 |
|
|
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer |
II/III |
Mikaela Esquivel (415) 353-7145 |
Pancreatic neuroendocrine tumors
|
Study Title |
National Clinical Trial number |
Phase |
Contact |
|
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver |
II |
Shawn Cheng (415) 514-7632 |
|
|
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors |
III |
Alex Milloy (415) 502-3310 |
|
|
Pembrolizumab in With Liver-Directed or Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors With Metastases |
II |
Eliot Lee (415) 476-1044 |
Non-Therapeutic trials
|
Study Title |
National Clinical Trial number |
Phase |
Contact |
|
Exploring the Role of the Intestinal Microbiome in Mediating Treatment Outcomes for Patients with Locally Advanced or Metastatic Pancreatic Cancer |
|
|
Taylor Sanchez (415) 885-7740 |
|
Panc Cyst Registry: Population-Based Analysis of Neoplastic Changes in Cystic Lesions of the Pancreas. |
|
Audrey Mustoe (415) 502-2131 |
Trials opening soon
|
Study Title |
National Clinical Trial number |
Phase |
|
|
THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients with Advanced Pancreatic Cancer |
I |
Nancy Kaushal (415) 514-7633 |
|
|
e-NET: A Pilot Study Using a Web-Based Health Platform to Investigate Health-Related Quality of Life in Patients with Neuroendocrine Tumors |
|
|
Julia Whitman (415) 353-7683 |